Metabolic reprogramming of cancer is mainly driven by diverse oncogenic pathways and oncogenes (e.g., PI3K/Akt/mTOR pathway, hypoxia-inducible factor, Ras, c-Myc) 18, 19. The gene discussed is MTOR; the disease is cancer.